Chemoradiation in conservation therapy for esophageal cancer

Hematology/Oncology Clinics of North America

Volumn 15, Issue 2, 2001, Pages 291-302

  Rich, Tyvin ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C; PACLITAXEL;

ACUTE TOXICITY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTINUOUS INFUSION; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; ESOPHAGUS FUNCTION; ESOPHAGUS STRICTURE; HISTOGRAM; HUMAN; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MYOCARDITIS; NEUTROPENIA; ORGAN PRESERVATION; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SURVIVAL RATE; TREATMENT CONTRAINDICATION;

EID: 0035030165     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70213-6     Document Type: Article

References (33)

1. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy
2. Radiotherapy in the treatment of carcinoma of the esophagus
3. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer
4. Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancer
5. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer
6. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma
7. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01)
8. Significance of prone positioning in planning treatment for esophageal cancer
9. Oesophageal squamous cell carcinoma. II. A critical review of radiotherapy
10. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus
11. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus. (Radiation Therapy Oncology Group Study 9207): Final report
12. Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment of followed by surgery
13. Intracavitary brachytherapy combined with external-beam irradiation for squamous cell carcinoma of the thoracic esophagus
14. Intracavitary radiation in the treatment of advanced esophageal carcinoma: A comparison of high dose rate vs. low dose rate brachytherapy
15. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus
16. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
17. Palliation in esophageal cancer with a single session of intraluminal irradiation
18. Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for esophageal carcinoma
19. Nonoperative therapy for squamous-cell cancer of the esophagus
20. Radiation therapy of esophageal carcinoma: Correlation of clinical and radiographic findings
21. Sequential infusion of 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction
22. Preoperative radiation therapy for carcinoma of the esophagus
23. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-FU and radiation therapy in localized esophageal cancer. Preliminary results of a Minnie Pearl cancer research network phase II trial
24. Preliminary results of intergroup INT 0123 randomized trial of combined modality therapy (CMT) for esophageal cancer: Standard vs. high dose radiation therapy
25. Relationship between the radiologic features of esophageal cancer and the local control by radiation therapy
26. Esophageal cancer treated with radiotherapy: Impact of total treatment time and fractionation
27. High dose rate intraluminal radiation in a combined modality treatment plan for carcinoma of the esophagus
28. Chemoradiation or accelerated fractionation: Basic considerations
29. Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: A prospective, randomized, and controlled study
30. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy
31. Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy radiotherapy and surgical therapy
32. A randomized trial comparing transhiatial esophagectomy to preoperative chemoradiation followed by esophagectomy in locoregional esophageal carcinoma
33. Non-cancerous ulcer in the esophagus after radiotherapy for esophageal carcinoma - A report of 27 patients